# Biodel Inc: Form D filing

Biodel Inc, a pharmaceuticals company in Danbury, CT, filed a Form D with the SEC in 2012. The latest, on June 29, 2012, reports $18.5 million sold of a $18.5 million offering to 19 investors.

Find out what Biodel Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Biodel%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Biodel%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fbiodel-inc-1322505)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Biodel%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Biodel%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fbiodel-inc-1322505)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut): 428 rows, by operating companies, filed since November 1, 2024, $21.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/connecticut
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 100 SAW MILL ROAD, Danbury, CT, 06810
- Phone: (203) 796-5000
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1322505

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 29, 2012 | New notice | $18,500,002 | $18,500,002 | $0 | 19 | Jun 27, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1322505/000132250512000003/0001322505-12-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Daniel W. Lorber | Director |  |
| Alan S. Krasner | Executive Officer |  |
| Davey S. Scoon | Director |  |
| Brian J.G. Pereira | Director |  |
| Gerard J. Michel | Executive Officer |  |
| Paul S. Bavier | Executive Officer |  |
| Julie R. Brown | Director |  |
| Barry S. Ginsberg | Director |  |
| Ira W. Lieberman | Director |  |
| Errol B. De Souza | Executive Officer, Director |  |
| Erik S. Steiner | Executive Officer |  |

## Other pharmaceuticals companies in Connecticut that filed recently

- [Thetis Pharmaceuticals LLC](https://specstream.ai/data/form-d/company/thetis-pharmaceuticals-llc-1528491) $560,300 · Oct 13, 2026
- [Inventure, LLC](https://specstream.ai/data/form-d/company/inventure-llc-1706556) $82,345 · Sep 3, 2026

[Every Form D from the week of Jun 25, 2012](https://specstream.ai/data/form-d/week/2012-06-25) · [All recent filings in Connecticut](https://specstream.ai/data/form-d/state/connecticut) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Biodel Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).